Ongoing work in this model, which does not carry mutations in the BRAF and PTEN genes frequently associated with melanoma (43, 44), may be particularly relevant to understanding the progression of the still large percentage of melanomas not driven by mutations in these two genes. This evidence concerns the gene BRAF and melanoma.